Mankind Pharma

Pharma Industry Ka Sach, Medicine, Condom Sales explained by Mankind’s Founder Rajeev Juneja | TRS

Why Mankind Pharma is different from other Pharma Companies?

Mankind Pharma's Grand Showcase on Burj Khalifa | A Glorious Moment of Excellence | 20th July, 2023

Celebrating Compassionate Caregivers | International Nurses Day | 12th May

Hum Se Behtar Hum || Aatmanirbhar Bharat || Kailash Kher || ManKind Pharma

Celebrating Onam, Celebrating Health | Mohanlal | Mankind Pharma

Mankind Pharma | #SpreadingKindness ft. Piyush Mishra | Diwali 2020 | Hindi

Bharat Serums Has Potential To Become a ₹4,000 to ₹5,000 Cr Company: Mankind Pharma To NDTV Profit

BSE Share News | Rec Share Latest News | Hindalco.Ongc.Ioc.Heg.Inox Wind.Reliance Infra.Share News

Mankind Pharma | Doctor's Day | Serving Life

Journey of Mankind by Mr. Rajeev Juneja, MD & Vice Chairman

Mankind Pharma Will Acquire Bharat Serums From Advent Intl In A Deal Worth ₹13,630 Cr | CNBC TV18

Iss Diwali nafrat mitaate hain | Happy Diwali 2022 | #NekiKiLauJalaateHain | Hindi | Mankind Pharma

Mankind Pharma Strong Growth In Q4, Board Approves ₹7,500 Cr. Fundraise, What's The Agenda? | ET Now

Mankind Pharma: A Tribute To The Medical Fraternity | #ThanksForBeingMyFamily

Bharat Serums' Acquisition Is Very Attractive From A Financial, R&D Perspective: Mankind Pharma

Mankind Pharma Q1 Earnings: Uptick In Gross Margins, What's The FY25 Future Outlook? | Rajeev Juneja

Ask Basant : Mankind Pharma and other stocks - 24th April 2023

BSV Deal Is Approx ₹14,000 Cr & We Intend To Fund ₹4,000 Cr Via Internal Accruals: Mankind Pharma

Inside Mankind Pharma's Big Rs 13,600 Crore Acquisition Of BSV I Mankind Pharma News

Mankind Pharma: Aim To Grow Chronic Biz, What Targets Set For Expansion In FY25 By The Company?

Mankind Pharma Ltd Q1 FY2024-25 Earnings Conference Call

Full Episode | The Great Indian Factory | Mankind Pharma’s Journey To Building A Healthier Bharat